The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Externalizing and Attentional Behaviors in Children of Depressed Mothers Treated With a Selective Serotonin Reuptake Inhibitor Antidepressant During Pregnancy
Abstract
OBJECTIVE: To evaluate attentional and activity behaviors in 4-year-olds following prenatal selective serotonin reuptake inhibitor (SSRI) exposure. DESIGN: Prospective cohort design. SETTING: Tertiary care center. PARTICIPANTS: Twenty-two 4-year-olds with prolonged prenatal SSRI medication exposure and 14 children without prenatal exposure. MAIN EXPOSURE: Prenatal SSRI exposure. MAIN OUTCOME MEASURES: Group differences in externalizing behaviors (according to the Child Behavior Checklist) and direct observations of child attention, activity, and impulsiveness in a laboratory setting using the procedure by Crowell and colleagues were compared, including measures of the duration of prenatal SSRI exposure, umbilical cord drug levels, a history of poor neonatal adaptation, and maternal mood. RESULTS: Externalizing behaviors did not differ between groups. Maternal depression and anxiety at the 4-year follow-up were associated with increased reports of externalizing behaviors. Increased externalizing behaviors were associated with increased umbilical cord drug levels (F(1,34) = 6.3; P = .02), but when controlling for maternal depressed mood at the 4-year follow-up, such levels only accounted for 11.2% of the behavioral outcomes (P>.05). On direct observation, the persistence score for child behavior was significantly lower in the exposed group. Increased aggressiveness scores were associated with a history of poor neonatal adaptation, even when parental report of stress was added to the model (F(1,34) = 4.0; P = .03); however, neither parental report of stress nor poor neonatal adaptation were significant (both P = .09), suggesting that both are important, if not unique, predictors of child behavior. CONCLUSIONS: These findings suggest that the best predictors of externalizing behaviors at age 4 years are current maternal mood and parental stress, regardless of prenatal depressed mood and SSRI treatment during pregnancy. It remains uncertain whether poor neonatal adaptation can be excluded as a possible predictor of externalizing behaviors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonsystematic reviews have indicated that the risks to children of untreated depressed mothers (compared to mothers without PPD) include problems such as poor cognitive functioning, behavioral inhibition, emotional maladjustment, violent behavior, externalizing disorders, and psychiatric and medical disorders in adolescence.5,10–17”
From Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes (2019) · cites this paper as [13]
In the citing paper
“Untreated PPD seems to have negative consequences for both infants and mothers.”
From Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes (2019) · cites this paper as [13]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Cohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,273
Antenatal Anxiety Predicts Child Behavioral/Emotional Problems Independently of Postnatal Depression
O’Connor, T. G., Heron, J., & Glover, V. A. S. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00019 · Cited by 592
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Nulman, I., ROVET, J. F., Stewart, D. E., Wolpin, J., Gardner, H. A., Theis, J. G. W., Kulin, N. A., & Koren, G. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360404 · Cited by 572
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Self-citationNeonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors
Moses‐Kolko, E. L., Bogen, D. L., Perel, J. M., Bregar, A. J., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 532
Brennan, P. A., Hammen, C. L., Andersen, M. J., Bor, W., Najman, J. M., & Williams, G. M. (2000) · Developmental Psychology · doi:10.1037//0012-1649.36.6.759 · Cited by 519
Longitudinal Study of Maternal Depressive Symptoms and Child Well-Being
LUOMA, I., TAMMINEN, T., KAUKONEN, P., LAIPPALA, P., PUURA, K., SALMELIN, R., & ALMQVIST, F. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200112000-00006 · Cited by 490
Prenatal exposure to maternal stress and subsequent schizophrenia
van Os, J., & Selten, J. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.4.324 · Cited by 481
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–198 of 198
Gemmel, M., Kokras, N., Dalla, C., & Pawluski, J. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.009 · Cited by 30
Amani, M., Houwing, D. J., Homberg, J. R., & Salari, A. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.06.014 · Cited by 31
Prenatal Antidepressant Exposure and Child Motor Development: A Meta-analysis
Grove, K., Lewis, A. J., & Galbally, M. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0356 · Cited by 29
Araújo, J. N. D. M., Delgado, I. F., & Paumgartten, F. J. R. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00026619 · Cited by 32
Child developmental outcomes in preschool children following antidepressant exposure in pregnancy
Galbally, M., Lewis, A. J., & Buist, A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415569800 · Cited by 27
Serotonin Reuptake Inhibitor-Induced Perinatal Complications
Gentile, S. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709020-00003 · Cited by 27
Malm, H. T., Artama, M., Brown, A. S., Gissler, M., Gyllenberg, D., Hinkka‐Yli‐Salomäki, S., McKeague, I. W., & Sourander, A. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-217 · Cited by 25
Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations
Banushi, B., Collova, J. R., & Milroy, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073075 · Cited by 30
Pei, S., Liu, L., Zhong, Z., Wang, H., Lin, S., & Shang, J. (2016) · Scientific Reports · doi:10.1038/srep33822 · Cited by 27
Pharmacotherapy for Perinatal Depression
Lusskin, S. I., Khan, S. J., Ernst, C. L., Habib, S. M., Fersh, M. E., & Albertini, E. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000365 · Cited by 27
Swerts, C. A. S., Costa, A. M. D. D., Esteves, A., Borato, C. E. S., & Swerts, M. S. O. (2009) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462009005000015 · Cited by 24
Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA
Schaefer, T. L., Grace, C. E., Braun, A. A., Amos‐Kroohs, R. M., Graham, D. L., Skelton, M. R., Williams, M. T., & Vorhees, C. V. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001447 · Cited by 23
Child Neuropsychology: A Journal on Normal and Abnormal Development in Childhood and Adolescence
Augusti, E., Torheim, H. K., & Melinder, A. M. D. (2014) · Cited by 23
Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges
EPSTEIN, R. A., Moore, K. M., & Bobo, W. V. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s43308 · Cited by 22
Yang, F., Chen, J., Miao, M., Yuan, W., Li, L., Liang, H., Ehrenstein, V., & Li, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016368 · Cited by 22
Pawluski, J. L., & Gemmel, M. (2018) · HORMONES · doi:10.1007/s42000-018-0011-y · Cited by 21
Grieb, Z. A., & Ragan, C. M. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.239 · Cited by 21
Gur, T., Kim, D. R., & Epperson, C. N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3115-8 · Cited by 21
Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study
Bliddal, M., Wesselhoeft, R. T., Strandberg‐Larsen, K., Ernst, M. T., Weissman, M. M., Gingrich, J. A., Talati, A., & Pottegård, A. (2023) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-023-00624-9 · Cited by 20
Williams, S. K., Lauder, J. M., & Johns, J. M. (2011) · Current Neuropharmacology · doi:10.2174/157015911796557957 · Cited by 18
The Use of Antidepressants in Pregnancy: Focus on Maternal Risks
Gadot, Y., & Koren, G. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30364-9 · Cited by 19
Neurobehavioral risks of SSRIs in pregnancy: Comparing human and animal data
Ornoy, A. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.05.003 · Cited by 21
Margolis, K. G. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.02.001 · Cited by 16
Bögi, E., Belovičová, K., Moravčíková, L., Csatlósová, K., Dremencov, E., Lacinová, Ľ., & Dubovický, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112131 · Cited by 16
Houwing, D. J., Esquivel-Franco, D. C., Ramsteijn, A. S., Schuttel, K., Struik, E. L., Arling, C., de Boer, S. F., & Olivier, J. D. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05535-7 · Cited by 16
Mood Disorders And Their Pharmacological Treatment During Pregnancy: Is the Future Child Affected?
Monk, C. E., Fitelson, E. M., & Werner, E. A. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182131a2e · Cited by 16
Svirin, E. P., Veniaminova, E. A., Costa-Nunes, J. P., Вячеславовна, Г. А., Umriukhin, A., Kalueff, A. V., Proshin, A. T., Anthony, D. C., Nedorubov, A. A., Tse, A. C.-K., et al. (2022) · Cells · doi:10.3390/cells11061036 · Cited by 12
Shorey, S., Chee, C. Y. I., Chong, Y. S., Ng, E. D., Lau, Y., & Dennis, C. (2018) · PubMed Central · doi:10.2196/resprot.9416 · Cited by 12
Rotem‐Kohavi, N., Williams, L. J., & Oberlander, T. F. (2020) · Seminars in Perinatology · doi:10.1016/j.semperi.2020.151223 · Cited by 12
Self-citationCasper, R. C. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000258 · Cited by 11
Warnock, F., Bakeman, R. A., Shearer, K., Misri, S. K., & Oberlander, T. F. (2009) · Infant Mental Health Journal · doi:10.1002/imhj.20220 · Cited by 11
Self-citationThe risks associated with prenatal antidepressant exposure: time for a precision medicine approach
Pedersen, L. H. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1341872 · Cited by 12
Bradley, H. A., Campbell, S. A., Mulder, R., Henderson, J. M. T., Dixon, L., Boden, J. M., & Rucklidge, J. J. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03143-z · Cited by 12
Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?
Pedersen, L. H. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0141-5 · Cited by 11
Neuenschwander, R., & Oberlander, T. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-55376-4_6 · Cited by 12
Self-citationHermansen, T. K., Yrttiaho, S., Røysamb, E., & Melinder, A. M. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4467-7 · Cited by 10
Dwarakanath, M., Hossain, F., Balascio, P., Moore, M., Hill, A. V., & Genna, N. M. D. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05929-3 · Cited by 11
The biology of fetal exposure to serotonin reuptake inhibitors: Implications for neurodevelopment
Galbally, M., Lewis, A. J., Gentile, S., Walker, S. P., & Buist, A. (2012) · Murdoch University Research Portal · Cited by 8
Troutman, B., & Momany, A. M. (2012) · Journal of Reproductive and Infant Psychology · doi:10.1080/02646838.2012.717263 · Cited by 9
Fenger‐Grøn, J., Thomsen, M., Andersen, K. S., & Nielsen, R. G. (2011) · PubMed · Cited by 8
Hay, R. E., Reynolds, J. E., Grohs, M., Paniukov, D., Giesbrecht, G. F., Letourneau, N., Dewey, D., & Lebel, C. (2019) · doi:10.1101/692335 · Cited by 7
Oberlander, T. F., & Wisner, K. L. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700901 · Cited by 7
Self-citationZahra, A., Du, L., Jia, M., Butt, M. U., Wang, Q., Wang, Y., & Wu, J. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102061 · Cited by 7
Staal, L., Plösch, T., Kallak, T. K., Poromaa, I. S., Wertheim, B., & Olivier, J. D. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00621 · Cited by 6
Determinants of Postpartum Depression In Rural Area, Central Java, Indonesia
Estiningtyas, & Cahyaningtyas, A. Y. (2021) · Journal of Health Science and Prevention · doi:10.29080/jhsp.v5i1.464 · Cited by 8
Singh, K. P., Singh, P., Agrawal, P., & Agarwal, B. (2023) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2023.11502 · Cited by 6
Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges
Koren, G., Clark, S. M., & Matsui, D. M. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/206179 · Cited by 6
Bromley, R., Wieck, A., MAKAROVA, D., Tower, C. L., WOOD, A. G., & Clayton‐Smith, J. (2012) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539512000095 · Cited by 6
Maternal mental health: a shared care approach
Li, H., Bowen, A., Szafron, M., Moraros, J., & Muhajarine, N. (2015) · Primary Health Care Research & Development · doi:10.1017/s146342361500033x · Cited by 6
Antidepressants during pregnancy, risks for mother and child
Ververs, T. F. (2009) · Utrecht University Repository (Utrecht University) · Cited by 5
Rahn, R. M., Maloney, S. E., Brier, L. M., Dougherty, J. D., & Culver, J. P. (2019) · eNeuro · doi:10.1523/eneuro.0238-19.2019 · Cited by 4
Houwing, D. J., de Waard, J., Ramsteijn, A. S., Woelders, T., de Boer, S. F., Wams, E. J., & Olivier, J. D. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05556-2 · Cited by 5
Rotem‐Kohavi, N., Goodman, S. H., Wazana, A. D., & Oberlander, T. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-60159-1_19 · Cited by 4
Self-citationNiforatos, J. D., Swetlik, C., & Viguera, A. C. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_8 · Cited by 4
Campbell, K. S. J., Brain, U. M., Hanley, G. E., Oberlander, T. F., & Lim, K. I. (2024) · Early Human Development · doi:10.1016/j.earlhumdev.2024.106129 · Cited by 3
Self-citationDiagnosis and Treatment of Depression During Pregnancy and Lactation
Shaw, D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_8 · Cited by 3
Rodrigues, W. D. S., Oliveira-Silva, P., Faria‐Melibeu, A. D. C., Campello‐Costa, P., & Serfaty, C. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.047 · Cited by 3
Steyn, S. F. (2011) · Boloka Institutional Repository (North-west University) · Cited by 3
Anns, F., Waldie, K. E., Peterson, E. R., Walker, C. G., Morton, S., & D’Souza, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.097 · Cited by 2
Alonso, M. B., Mora, C. M., Torres, J. A., Santaella, C. C., Enciso, F. C., & Bensabat, M. A. (2008) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(08)71096-3 · Cited by 2
Mougharbel, F., & Deonandan, R. (2016) · Global Journal of Health Science · doi:10.5539/gjhs.v9n3p304 · Cited by 2
Bondi, D. S., Khan, O., & Hageman, J. R. (2016) · NeoReviews · doi:10.1542/neo.17-7-e356 · Cited by 2
The Effects of SSRI Treatment on Human Placenta and Embryo
Kaihola, H. (2015) · Uppsala University Publications (Uppsala University) · Cited by 2
Chatillon, O. (2010) · Cited by 1
Advances in Pediatric Pharmacology, Therapeutics, and Toxicology
Paul, I. M. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.08.004 · Cited by 1
The Role of Family Support Towards Perinatal Depression in Medan
Sitorus, N. Y., Putri, P. S., & Kaban, N. B. (2024) · International Journal of Public Health Excellence (IJPHE) · doi:10.55299/ijphe.v3i2.759 · Cited by 1
Anosike, C., Osefo, R. C., Isiogugu, O. N., Nwachukwu, E. C., Agu, U. K., Nwaji, J. C., & Ogbu, M.-E. A. (2024) · Mental Health and Social Inclusion · doi:10.1108/mhsi-12-2023-0138 · Cited by 2
Bérard, A., & Ramos, L. (2007) · médecine/sciences · doi:10.1051/medsci/20072311957 · Cited by 1
Chapter 63. Psychopharmacology During Pregnancy and Lactation
Newport, D. J., di Scalea, T. L., Richardson, E., Smith, T. L., Scott, N. P., & Stowe, Z. N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as63 · Cited by 1
Antidepressant Use in Perinatal Depression
Forray, A., Blackwell, K. A., & Yonkers, K. A. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch114
Fæðingarþunglyndi. Endurmat á vinnuleiðbeiningum með EPDS kvarðanum
Guðmundsdóttir, A. K., & Bárðardóttir, H. H. (2011)
Psychiatric Disorders in Pregnancy
Pearlstein, T. B., & Star, J. (2010) · Wiley eBooks · doi:10.1002/9781444323016.ch21
Teplin, S. W., Macias, M. M., Mansoor, E., & Murray, K. E. (2009) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31819cf544
Optimizing Neurodevelopmental Outcomes in Infants and Children Following Prenatal SSRI Exposure
Oberlander, T. F. (2009) · Pediatric Health · doi:10.2217/phe.09.56
Self-citationIII Jornada de Salud Mental Perinatal
Lasheras, G., Farré-Sender, B., Ferraz, L., Mestre‐Bach, G., Rovira, I., & Toro, J. M. (2014)
Swerts, C. A. S., Costa, A. M. D. D., Esteves, A., Borato, C. E. S., & Swerts, M. S. O. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
Risques et bénéfices pour la mère et l'enfant
Bérard, A., & Ramos, É. (2007)
Antidepressant use during pregnancy
Frieder, A. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.11.24
Fetal Effects of In Utero Serotonin Reuptake Inhibitor (SRI) Antidepressant Exposure
Hanley, G. E., Hookenson, K., Rurak, D. W., & Oberlander, T. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-22023-9_18 · Cited by 1
Self-citationManagement of Depression and Psychoses in Pregnancy and the Puerperium
Yonkers, K. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50056-9
Psychotropic Medication in Pregnancy: Focus on Child Outcomes
Power, J., Galbally, M., & Lewis, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-32358-9_6
Kruger, R. (2014) · Boloka Institutional Repository (North-west University)
Staal, L., & Olivier, J. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83761
Wood, M. E., Eilertsen, E. M., Ystrøm, E., Nordeng, H., & Hernández–Dı́az, S. (2020) · Research Square · doi:10.1101/2020.06.11.20128496
Effects of developmental fluoxetine exposure on neurobehavioral outcomes
Rayen, I. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131023ir
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1376
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.795
Shorey, S., Chee, C. Y. I., Chong, Y. S., Ng, E. D., Lau, Y., & Dennis, C. (2017) · doi:10.2196/preprints.9416
Teplin, S. W., Macias, M. M., Mansoor, E., & REIFF, M. I. (2007) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/01.dbp.0000267555.03705.59
Gidey, S. N., Tefera, F., Ababiya, T. H., Fissehatsion, F. A., Teka, B., Zergaw, R., Urgecha, E., Habtegiorgis, Y., Bate, Z., & seifu, A. K. (2025) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20251302.12 · Cited by 1
Bliddal, M., Wesselhoeft, R. T., Strandberg-Larsen, K., Ernst, M., Weissman, M. M., Gingrich, J. A., Talati, A., & Pottegård, A. (2023) · Figshare · doi:10.6084/m9.figshare.23536161
Cannon, R. L. (2026) · NeuroRegulation · doi:10.15540/nr.13.1.91
Serotonin and emotional behaviours : developmental role of the 5-HT7 receptor
Olusakin, J. (2019) · theses.fr (ABES) · doi:10.70675/480ab91dz9252z4d95z8749z992be4697690
Conséquences à long terme de l'exposition in utero à des médicaments
Bénevent, J. (2020) · theses.fr (ABES) · doi:10.70675/2e0fc5b0zb9b0z4d14zb36fze45f1f941d25
Cook, K. M., Kim, J., Andescavage, N. N., Kapse, K. J., Limperopoulos, C., & Asis‐Cruz, J. D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1830026
Self-citationPsychotropic Medications in Pregnancy
Nulman, I., Terrana, N., Lutwak, M., & Pearlston, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15750-4_25
Antidepressants in pregnancy: a systematic review.
(2010) · PubMed · doi:10.3109/00048674.2010.507543 · Cited by 128
Metadata
- Authors
- Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E.
- Affiliations
- University of British Columbia (CA)
- Venue
- Archives of Pediatrics & Adolescent Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-01-01
- Volume
- 161
- Issue
- 1
- Pages
- 22
- ISSN
- 1072-4710 (ISSN-L)
- OpenAlex
- W2164579326
- Cited by
- 198
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 13 · 2019: 14 · 2018: 9 · 2017: 13 · 2016: 13 · 2015: 14 · 2014: 12 · 2013: 14 · 2012: 13
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Pediatrics and Adolescent Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- prenatal SSRI exposure, selective serotonin reuptake inhibitors, maternal depression, externalizing problems, attention, impulsivity, neonatal adaptation, parental stress, maternal mood, child behavior, autism spectrum disorder risk
- MeSH terms
- Adult, Attention, Child Behavior, Child, Preschool, Depression, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Pregnancy, Pregnancy Complications, Prognosis, Prospective Studies, Risk Factors, Selective Serotonin Reuptake Inhibitors, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review